Status:
COMPLETED
Coaching for HCV and HIV
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Boston University
Conditions:
Hepatitis C
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to determine the feasibility and acceptability of a peer recovery coach (PRC) intervention to improve linkage to hepatitis C (HCV) and/or human immunodeficiency virus (H...
Detailed Description
\*NOTE\* Due to the COVID-19 pandemic, surveys were conducted via telephone and not all participants could be contacted. Therefore, the number of results from participants at three months and six mont...
Eligibility Criteria
Inclusion
- Individuals with opioid use disorder, non-reactive HIV antibody test and reactive HCV antibody testing at the BMC LBA walk-in clinic
- Able to speak English
- Individuals providing contact information of two family members or friends
- Individuals signing a medical records release form
Exclusion
- Individuals already linked to substance use care
- Individuals co-infected with HIV and HCV and engaged in care
Key Trial Info
Start Date :
December 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2022
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04314414
Start Date
December 20 2020
End Date
January 28 2022
Last Update
December 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center - Low-Barrier-Access (LBA) walk-in clinic
Boston, Massachusetts, United States, 02118